Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
GlaxoSmithKline Medicines Research Centre was the worlds sixth-largest pharmaceutical company which has its headquarters in Brentford, London. It was established in the year 2000 by the merger of Glaxo Wellcome and SmithKline Beecham plc. GlaxoSmithKline Medicines Research Centre manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. GlaxoSmithKline received top ranking among international pharmaceutical companies in the Access to Medicines Index in both 2010 and 2012. GlaxoSmithKline Medicines Research Centre acquired Stiefel Laboratories in 2009 which was the worlds largest independent dermatology drug company at the time. It has also acquired CellZome, a German biotech company with a proteomics-based drug discovery platform in the year 2012 with which GSK had collaborated for the past four years. HGS and GSK had collaborated on the development of two drugs that received marketing approval, the lupus drug Belimumab (Benlysta) and albiglutide for type 2 diabetes, and on a drug in development darapladib for atherosclerosis.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi